News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Emphasys Medical Cancels Plans for IPO
May 13, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (AP) -- Emphasys Medical Inc., which developed a medical device to treat emphysema, has canceled its plans for an initial public offering, citing market conditions, according to a Securities and Exchange Commission filing Monday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst
Mergers & acquisitions
GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year
June 9, 2026
·
2 min read
·
Tristan Manalac
Deals
J&J glows with $1B buyout of Firefly and its degrader platform tech
June 8, 2026
·
1 min read
·
Gabrielle Masson
Mergers & acquisitions
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset
June 8, 2026
·
2 min read
·
Annalee Armstrong
